GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 185 filers reported holding GW PHARMACEUTICALS PLC in Q1 2017. The put-call ratio across all filers is 1.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $706,000 | -0.1% | 7,373 | +20.0% | 0.00% | -20.0% |
Q3 2019 | $707,000 | -18.8% | 6,143 | +21.7% | 0.01% | -16.7% |
Q2 2019 | $871,000 | +13.9% | 5,049 | +11.3% | 0.01% | 0.0% |
Q1 2019 | $765,000 | +90.3% | 4,535 | +10.3% | 0.01% | +50.0% |
Q4 2018 | $402,000 | -35.3% | 4,112 | +13.9% | 0.00% | -20.0% |
Q3 2018 | $621,000 | +80.5% | 3,610 | +18.1% | 0.01% | +66.7% |
Q2 2018 | $344,000 | 0.0% | 3,057 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $344,000 | +6.8% | 3,057 | +25.4% | 0.00% | 0.0% |
Q4 2017 | $322,000 | +9.5% | 2,438 | -15.6% | 0.00% | 0.0% |
Q3 2017 | $294,000 | +51.5% | 2,887 | +49.5% | 0.00% | +50.0% |
Q2 2017 | $194,000 | -17.1% | 1,931 | -0.8% | 0.00% | -33.3% |
Q1 2017 | $234,000 | +7.3% | 1,946 | +1.6% | 0.00% | 0.0% |
Q4 2016 | $218,000 | -7.2% | 1,916 | +8.0% | 0.00% | -25.0% |
Q3 2016 | $235,000 | +30.6% | 1,774 | -9.9% | 0.00% | +33.3% |
Q2 2016 | $180,000 | +27.7% | 1,970 | +0.5% | 0.00% | +50.0% |
Q1 2016 | $141,000 | +15.6% | 1,960 | +12.3% | 0.00% | 0.0% |
Q4 2015 | $122,000 | +23.2% | 1,746 | +62.1% | 0.00% | 0.0% |
Q3 2015 | $99,000 | -41.4% | 1,077 | -21.6% | 0.00% | -33.3% |
Q2 2015 | $169,000 | +32.0% | 1,374 | -1.5% | 0.00% | +50.0% |
Q1 2015 | $128,000 | +814.3% | 1,395 | +554.9% | 0.00% | – |
Q4 2014 | $14,000 | -63.2% | 213 | -54.7% | 0.00% | -100.0% |
Q3 2014 | $38,000 | -65.1% | 470 | -53.9% | 0.00% | -66.7% |
Q2 2014 | $109,000 | +808.3% | 1,020 | +410.0% | 0.00% | – |
Q1 2014 | $12,000 | +50.0% | 200 | 0.0% | 0.00% | – |
Q4 2013 | $8,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|